The 2nd KTN Biopharmaceutical Analytical Group Symposium will present the latest developments in bioanalytical characterisation relating to emerging technologies and will look in detail at some of the analytical challenge areas.  As pipelines move forward to include the next generation of biopharmaceutical products, analytics and technologies underpinning them must keep pace to reflect it.  This two day meeting will enable the UK biopharmaceutical analytical community to discuss areas of interest, understand the challenges and latest technologies available, while networking with your peers in this field and make new contacts.

Register here

The agenda is being finalised and delegates will have the chance to listen to and discuss a wide range of themes including:

• Analytics of Emerging Formats/Therapies: Focusing on products such as: ADC’s, vaccines, viral vectors, scaffold proteins, cell therapies
• Analytical Challenge Areas: Including talks on predictive analytics and process analytics
• Technology Showcase: Highlighting relevant case studies and utilising the emerging and evolving analytical techniques from both industry and academic communities
• KTN Community Update: There will also be a review and discussion on the latest updates on initiatives relevant to the space

Confirmed speakers:

• Alistair Kippen – Medimmune
• Allan Davidson – Piramal
• Daniel Smith – Cobra Biologics
• Tarit Mukhopadhyay – UCL
• Milena Quaglia – LGC
• Paul Ko Ferrigno – Avacta Life Sciences
• Grant Grieve – Fujifilm DioSynth Biotechnologies
• Frank Craig – Sphere Fluidics
• James Graham – Lonza
• Ashleigh Wake – Intertek
• Paul Dalby – UCL
• Christoph Walti – University of Leeds
• Damien Marshall – CT Catapult
• Mary Collins – NIBSC
• Donna McLaren – ReNeuron
• Mark Dickman – University of Sheffield
• Dave Goodall – Paraytec
• Christoph Walti – University of Leeds

View event details here